1525 Superior Avenue, Suite 200
Newport Beach, CA 92663
Phone (949) 650-0506
Fax (949) 999-8126

Receive our newsletter
  Home  
  Our Team  
  Patient Info  
  Contact Us  

News for Healthier Living

Researchers Find New Target to Sensitize Pancreatic Tumors to Immunotherapy

* DPY30 acts as an epigenetic regulator to help pancreatic tumors maintain genomic stability * Targeting DPY30 triggers immune cell infiltration and sensitizes tumors to immunotherapy * DPY30 expression could predict which patients are more likely to benefit from immunotherapy * Therapeutic strategies could combine DPY30 inhibition with immunotherapy to improve patient outcomes

April 8, 2026


April 15 2026

April 14 2026

April 13 2026

April 12 2026

April 11 2026

April 10 2026

April 9 2026

April 8 2026

April 7 2026

April 6 2026

April 5 2026

April 4 2026

April 3 2026

April 2 2026

April 1 2026